Evidence map›Paper›PMID 23159167›Full record

ArticleVirology2013

Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway.

A Louise McCormick, Linda Roback, Grace Wynn, Edward S Mocarski

Abstract read
In one paragraph

Article in Virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Programmed Necrosis in Host Defense.Current topics in microbiology and immunology · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Viral modulation of programmed necrosis.Current opinion in virology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

A Louise McCormickDepartment of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, 1462 Clifton Rd NE, Atlanta, GA 30322, USA. alouisemccormick@gmail.com
Linda Roback
Grace Wynn
Edward S Mocarski
Emory Healthcare · US

Funding

CYTOMEGALOVIRUS DNA REPLICATION AND RECOMBINATIONR01AI020211 · NIAID · STANFORD UNIVERSITY · PI EDWARD S MOCARSKI, EDWARD S. · 1985 to 2021
$5.9M
NIAID NIH HHS R01 AI020211NIAID NIH HHS R01AI020211
6 · The paper itself

Abstract

At a low MOI (≤0.01), cytomegalovirus-associated programmed cell death terminates productive infection via a pathway triggered by the mitochondrial serine protease HtrA2/Omi. This infected cell death is associated with late phase replication events naturally suppressed by the viral mitochondrial inhibitor of apoptosis (vMIA). Here, higher MOI (ranging from 0.1-3.0) triggers cell death earlier during infection independent of viral DNA synthesis. Thus, MOI-dependent activating signals early, at high MOI, or late, at low MOI, during replication promote serine protease-dependent death that is suppressed by vMIA. Treatment with an antioxidant targeting reactive oxygen species (ROS) or the serine protease inhibitor N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK) delays cell death, and the combination has an additive impact. These studies identify serine proteases and ROS as important factors triggering programmed cell death induced by vMIA-deficient virus, and show that this death pathway occurs earlier and reduces viral yields as the MOI is increased.

Indexed as

ApoptosisCell DeathCells, CulturedCytomegalovirusCytopathogenic Effect, ViralFibroblastsHigh-Temperature Requirement A Serine Peptidase 2HumansMitochondriaMitochondrial ProteinsReactive Oxygen SpeciesSerine EndopeptidasesSerine Proteinase InhibitorsViral ProteinsVirus ReplicationHigh-Temperature Requirement A Serine Peptidase 2HTRA2 protein, humanMitochondrial ProteinsReactive Oxygen SpeciesSerine EndopeptidasesSerine Proteinase InhibitorsViral Proteins

Identifiers

PMID23159167
PMCPMC3534952
OpenAlexW1999718044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.